← Back to Search

Behavioral Intervention

Comparative information on tubal sterilization and other long-acting contraceptives for Birth Control

N/A

Waitlist Available

Led By Eleanor Schwarz, MD, MS

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 month follow-up

Awards & highlights

Study Summary

This trial aims to see if providing information to women who want to avoid pregnancy about tubal sterilization and long-acting reversible contraceptives helps them access contraceptives better. Participants will fill out

Who is the study for?

This trial is for women who do not wish to become pregnant in the future. Participants should be considering their options for permanent contraception and willing to complete surveys about their perceptions of contraceptive access after using educational websites.Check my eligibility

What is being tested?

The study tests if a new website with patient-centered information on tubal sterilization versus long-acting reversible contraceptives (LARC) affects women's views on contraceptive access, compared to an existing Planned Parenthood website.See study design

What are the potential side effects?

There are no direct physical side effects from participating in this trial as it involves gathering information from web-based resources rather than medical interventions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Perceived Access to Long Acting Contraceptives

Secondary outcome measures

Consumer Assessment of Healthcare Providers and Systems

Knowledge of Long-Acting Contraceptives

Patients' Perceived Efficacy in Patient-Physician Interactions (PEPPI)

+3 more

Other outcome measures

Suggestions for how to improve web-based resources for people considering permanent contraception.

Side effects data

From 2011 Phase 3 trial • 407 Patients • NCT01236768

Cervical dysplasia

Nasopharyngitis

Sinusitis

Sinus Congestion

Nausea

Upper respiratory infection

100%

80%

60%

40%

20%

Study treatment Arm

AG200-15

Levora

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Comparative information on tubal sterilization and other long-acting contraceptivesExperimental Treatment1 Intervention

A new website comparing tubal sterilization to vasectomy and long-acting reversible contraceptives

Group II: Information on tubal sterilizationActive Control1 Intervention

Participants will be shown an existing web page developed by Planned Parenthood for people considering tubal sterilization

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Agency for Healthcare Research and Quality (AHRQ)FED

399 Previous Clinical Trials

6,821,998 Total Patients Enrolled

Essential Access HealthOTHER

6 Previous Clinical Trials

2,520 Total Patients Enrolled

University of California, San FranciscoLead Sponsor

2,505 Previous Clinical Trials

15,237,205 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"Per clinicaltrials.gov, this particular research study is not actively seeking participants. Originally listed on April 1st, 2024 and last amended on February 29th, 2024. Despite this trial being inactive in terms of recruitment, there are currently 53 other trials open for patient enrollment at present."

Answered by AI

Which individuals meet the criteria for participation in this medical study?

"Prospective participants must be of reproductive age, between 21 and 45 years old, to meet the enrolment criteria for this trial. A total of 350 individuals will be accepted into the study."

Answered by AI

Is the trial open to individuals who are older than 50 years of age?

"Potential participants for this trial must have an age falling within the range of 21 to 45 years. It is noteworthy that there are specifically 21 investigations tailored for individuals under 18 and another set of studies, totaling 13, designed for those above the age of 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Patient-centered Information on Permanent Contraception

2024. "Patient-centered Information on Permanent Contraception". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06296797.